-
Rapid on-time onset and sustained improvements in motor states throughout the day following treatment with levodopa/carbidopa intestinal gel (LCIG) vs immediate-release levodopa/carbidopa oral capsules (LCIR)
-
Rare variants of the LRRK2 gene in the haplotype as one of the potential risk factors for endemic parkinsonism in a small isolated region in the Czech Republic
-
Rate of Neuromuscular Excitation during Cycling Related to Mobility in Parkinson’s Disease
-
Rates of Pharmacological Treatment of Neuropsychiatric Symptoms in Early Parkinson’s Disease
-
RBD and autonomic dysfunction in newly diagnosed Parkinson’s disease patients
-
Real Time Quality Control for Subjective Endpoints in Clinical Trials
-
Real World Clinical Outcomes Using a Novel Directional Lead from a Multicenter Registry of Deep Brain Stimulation for Parkinson’s Disease
-
Real-World Data on the Use of Levodopa-Carbidopa Intestinal Gel in Patients with Advanced Parkinson’s Disease who are Treated with Deep Brain Stimulation: The PD-DUAL Study
-
Real-World Deutetrabenazine Dosing Patterns in Patients With Huntington’s Disease or Tardive Dyskinesia
-
Real-World Evaluation of Patient Characteristics and Disease Management in Long-Term Valbenazine Treatment in Adults with Tardive Dyskinesia
- « Previous Page
- 1
- …
- 113
- 114
- 115
- 116
- 117
- …
- 149
- Next Page »